Peptide Receptor Radionuclide Therapy with
18F-FDG-PET/CT
68Ga-DOTATATE PET/MRI
PRRT
neuroendocrine tumor
Journal
Molecular imaging and radionuclide therapy
ISSN: 2146-1414
Titre abrégé: Mol Imaging Radionucl Ther
Pays: Turkey
ID NLM: 101584839
Informations de publication
Date de publication:
03 06 2021
03 06 2021
Historique:
entrez:
4
6
2021
pubmed:
5
6
2021
medline:
5
6
2021
Statut:
ppublish
Résumé
We present a partial response of peptide receptor radionuclide therapy (PRRT) with Bu olgu sunumunda eşzamanlı nöroendokrin tümör (NET) ve menenjiyom tanılı bir olgunun
Autres résumés
Type: Publisher
(tur)
Bu olgu sunumunda eşzamanlı nöroendokrin tümör (NET) ve menenjiyom tanılı bir olgunun
Identifiants
pubmed: 34082512
doi: 10.4274/mirt.galenos.2020.69783
pmc: PMC8185482
doi:
Types de publication
Journal Article
Langues
eng
Pagination
107-109Références
Neuro Oncol. 2016 Jul;18(7):1021-7
pubmed: 26865086
Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1407-16
pubmed: 19319527
Clin Nucl Med. 2015 Mar;40(3):237-40
pubmed: 25608146
Neuro Oncol. 2016 Nov;18(11):1538-1547
pubmed: 27106404
Endocr Relat Cancer. 2019 Feb 1;26(2):227-239
pubmed: 30540557